Bio Rad Laboratories Inc (NYSE:BIO)
| 628.23 Delayed Data As of Jan 14 |  -10.93 / -1.71%Today’s Change | 545.00 Today|||52-Week Range 832.70 | -16.85% Year-to-Date |
Latest BIO News | Press Releases
| Bio Rad's (BIO) Product Launches Aid, Forex Woes Persist Jan 13 / Zacks.com - Paid Partner Content | Shilanski & Associates, Inc. Buys Olin Corp, Coterra Energy Inc, Fortinet Inc, Sells Staar ... Jan 12 / GuruFocus News - Paid Partner Content |
| State of Alaska, Department of Revenue Buys Realty Income Corp, Bio-Rad Laboratories Inc, ... Jan 12 / GuruFocus News - Paid Partner Content |
Today’s Trading
| Previous close | 639.16 |
| Today’s open | 633.15 |
| Day’s range | 620.00 - 641.96 |
| Volume | 178,142 |
| Average volume (3 months) | 123,751 |
| Market cap | $15.6B |
Data as of 4:00pm ET, 01/14/2022
Growth & Valuation
| Earnings growth (last year) | +116.97% |
| Earnings growth (this year) | +45.66% |
| Earnings growth (next 5 years) | +14.00% |
| Revenue growth (last year) | +10.12% |
| P/E ratio | 2.8 |
| Price/Sales | 6.91 |
| Price/Book | 1.90 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| QGENQiagen NV | -0.19 | -0.39% |
| WATWaters Corp | -4.28 | -1.27% |
| BRKRBruker Corp | -0.11 | -0.16% |
| PKIPerkinElmer Inc | -1.23 | -0.69% |
Data as of 4:00pm ET, 01/14/2022
Financials
| Next reporting date | February 24, 2022 |
| EPS forecast (this quarter) | $2.87 |
| Annual revenue (last year) | $2.5B |
| Annual profit (last year) | $3.8B |
| Net profit margin | 149.52% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Hercules, California |
Forecasts
